论文部分内容阅读
目的:探讨参麦注射液对改善尘肺病患者肺部纤维化指标的作用。方法:选取近几年我院尘肺患者,种类为:煤工尘肺、矽尘、电焊尘肺等。尘肺分期为Ⅰ、Ⅱ期。将患者分为对照组和研究组。两组基础治疗方法相同,研究组加用参麦注射液。对比研究组和对照组治疗前后肺部纤维化血清指标PⅢ P、C Ⅳ及PⅠCP。结果:研究组和对照组治疗前肺部纤维化血清指标PⅢ P、C Ⅳ及PⅠCP比较无差异(P>0.05);研究组和对照组治疗后肺部纤维化血清指标PⅢ P、C Ⅳ及PⅠCP比较有差异(P<0.05)。结论:参麦注射液联合常规西医能够改善尘肺患者肺部纤维化情况,对延缓患者的疾病发展有重要意义。
Objective: To investigate the effect of Shenmai injection on pulmonary fibrosis in patients with pneumoconiosis. Methods: Select pneumoconiosis patients in our hospital in recent years, types: coal workers pneumoconiosis, silica dust, dust and other electrical welding. Pneumoconiosis stage Ⅰ, Ⅱ. The patients were divided into control group and study group. The same two groups of basic treatment, study group plus Shenmai injection. The pulmonary fibrosis serum indexes PⅢP, C Ⅳ and PⅠCP before and after treatment in the control group and the control group were compared. Results: There was no significant difference in PⅢP, C Ⅳ and PⅠCP between the study group and the control group before treatment (P> 0.05). The serum levels of P Ⅲ P and C Ⅳ PⅠCP difference (P <0.05). Conclusion: Shenmai injection combined with routine western medicine can improve pulmonary fibrosis in patients with pneumoconiosis, which is of great significance for delaying the development of the disease in patients.